We are live on
!
Find out more
MCM
Matarin Capital Management Portfolio holdings
AUM
$409M
Turnover
30.94%
1-Year Est. Return
33.03%
This Fund
S&P 500
This Quarter
Est. Return
+4.21%
1 Year Est. Return
+33.03%
3 Year Est. Return
+73.2%
5 Year Est. Return
+181.88%
10 Year Est. Return
–
AUM
$1.08B
AUM Growth
+$63.8M
(+6.3%)
Cap. Flow
+$34.9M
Cap. Flow
% of AUM
3.23%
Top 10 Holdings %
Top 10 Hldgs %
12.6%
Holding
322
New
38
Increased
152
Reduced
64
Closed
47
Avg Time Held
1.1
years
Top 10 Avg Time Held
0.5
years
Top 20 Avg Time Held
0.5
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eagle Pharmaceuticals, Inc.
EGRX
|
+$8.46M |
| 2 |
Hawaiian Holdings, Inc.
HA
|
+$8.23M |
| 3 |
LM
Legg Mason, Inc.
LM
|
+$7.93M |
| 4 |
CHSP
Chesapeake Lodging Trust
CHSP
|
+$7.89M |
| 5 |
Coca-Cola Consolidated
COKE
|
+$7.73M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
KCG
KCG Holdings, Inc.
KCG
|
+$9.43M |
| 2 |
MGLN
Magellan Health Services, Inc.
MGLN
|
+$8.69M |
| 3 |
ePlus
PLUS
|
+$8.06M |
| 4 |
Murphy USA
MUSA
|
+$7.57M |
| 5 |
Thor Industries
THO
|
+$7.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 17.53% |
| 2 | Industrials | 15.88% |
| 3 | Technology | 13.74% |
| 4 | Consumer Discretionary | 13.21% |
| 5 | Healthcare | 13.21% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
Trueblue
TBI
$260M
| $9.34M | 0.86% |
352,325
+24,625
| +8% | +$657K |
2015 Q3
7 quarters
|
|
27
TriNet
TNET
$3.23B
| $9.24M | 0.86% |
282,371
+139,064
| +97% | +$4.25M |
2017 Q1
1 quarter
|
|
28
Worthington Enterprises
WOR
$3.14B
| $9.21M | 0.85% |
297,460
+5,017
| +2% | +$135K |
2016 Q1
5 quarters
|
|
29
DELISTED
Radius Recycling
RDUS
| $9.02M | 0.83% |
357,911
-103,126
| -22% | -$2.04M |
2014 Q1
13 quarters
|
|
30
DELISTED
La Quinta Holdings Inc.
LQ
| $8.96M | 0.83% |
606,416
+21,380
| +4% | +$302K |
2017 Q1
1 quarter
|
|
31
Allegiant Air
ALGT
$1.92B
| $8.91M | 0.82% |
65,734
+2,221
| +3% | +$325K |
2013 Q2
16 quarters
|
|
32
Emergent Biosolutions
EBS
$368M
| $8.91M | 0.82% |
262,741
+5,075
| +2% | +$157K |
2013 Q2
16 quarters
|
|
33
DELISTED
Masimo
MASI
| $8.79M | 0.81% |
96,444
-50,217
| -34% | -$4.61M |
2017 Q1
1 quarter
|
|
|
AAWW
34
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $8.73M | 0.81% |
167,322
+126,538
| +310% | +$6.67M |
2017 Q1
1 quarter
|
|
35
Hilltop Holdings
HTH
$2.11B
| $8.67M | 0.8% |
330,837
+6,133
| +2% | +$163K |
2016 Q3
3 quarters
|
|
36
REX American Resources
REX
$1.39B
| $8.56M | 0.79% |
532,056
-21,954
| -4% | -$348K |
2014 Q4
10 quarters
|
|
37
Usana Health Sciences
USNA
$284M
| $8.51M | 0.79% |
132,801
-4,628
| -3% | -$285K |
2013 Q3
15 quarters
|
|
38
Stepan Co
SCL
$1.41B
| $8.48M | 0.78% |
97,307
-9,015
| -8% | -$758K |
2014 Q4
10 quarters
|
|
39
Insight Enterprises
NSIT
$4.66B
| $8.33M | 0.77% |
208,330
-21,844
| -9% | -$923K |
2013 Q2
16 quarters
|
|
40
Delek US
DK
$4.71B
| $8.29M | 0.77% |
313,700
+81,140
| +35% | +$2M |
2017 Q1
1 quarter
|
|
|
WDR
41
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $8.27M | 0.77% |
437,909
+42,542
| +11% | +$747K |
2015 Q3
7 quarters
|
|
42
ArcBest
ARCB
$2.97B
| $8.26M | 0.76% |
401,071
+14,287
| +4% | +$310K |
2013 Q2
16 quarters
|
|
|
HRC
43
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $8.24M | 0.76% |
103,480
+1,464
| +1% | +$111K |
2013 Q2
16 quarters
|
|
44
UMB Financial
UMBF
$10B
| $8.22M | 0.76% |
109,759
+2,716
| +3% | +$199K |
2016 Q2
4 quarters
|
|
|
45
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $8.16M | 0.76% |
+103,444
| New | +$8.46M |
2017 Q2
0 quarters
|
|
|
LM
46
DELISTED
Legg Mason, Inc.
LM
| $7.99M | 0.74% |
+209,463
| New | +$7.93M |
2017 Q2
0 quarters
|
|
|
DFT
47
DELISTED
DuPont Fabros Technology Inc.
DFT
| $7.88M | 0.73% |
128,781
-27,966
| -18% | -$1.54M |
2014 Q4
10 quarters
|
|
|
TECD
48
DELISTED
Tech Data Corp
TECD
| $7.83M | 0.72% |
77,532
+40,864
| +111% | +$3.93M |
2015 Q4
6 quarters
|
|
49
Titan International
TWI
$436M
| $7.83M | 0.72% |
651,955
-134,119
| -17% | -$1.45M |
2016 Q3
3 quarters
|
|
50
SiriusPoint
SPNT
$2.89B
| $7.79M | 0.72% |
560,457
+124,409
| +29% | +$1.58M |
2016 Q4
2 quarters
|
|
Similar funds
GBBWRPM
PSSGI
RA
TAM
SIVVM
SM
NFG
AWW
Matarin Capital Management's Q2 2017 Portfolio in Review
As of Q2 2017, Matarin Capital Management held 322 positions worth $1.08B, up 6.3% from $1.02B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Matarin Capital Management deployed $34.9M of net new capital in Q2 2017, opening 38 new positions and adding to 152 existing holdings. Its largest new stake was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
By sector, the portfolio is most concentrated in Financials at 18% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
On the sell side, the largest reduction was Magellan Health Services, Inc., an estimated $8.69M trimmed.
- Matarin Capital Management's largest Q2 2017 buy was Eagle Pharmaceuticals, Inc.: 103,444 shares worth $8.16M.
- Matarin Capital Management added most to Chesapeake Lodging Trust in Q2 2017, an estimated $7.89M increase.
- Matarin Capital Management's biggest Q2 2017 reduction was Magellan Health Services, Inc., cutting an estimated $8.69M.
- Matarin Capital Management fully exited KCG Holdings, Inc. in Q2 2017, selling an estimated $9.43M.
- Matarin Capital Management's ten largest holdings make up 13% of its $1.08B portfolio in Q2 2017.
- Matarin Capital Management opened 38 new positions and closed 47 in Q2 2017.
- Matarin Capital Management's portfolio value rose 6.3% quarter-over-quarter to $1.08B.
Based on Matarin Capital Management's 13F filing for Q2 2017, filed 9 Aug 2017.